Literature DB >> 10403566

Glucose rapidly decreases plasma membrane GLUT4 content in rat skeletal muscle.

A Marette1, D Dimitrakoudis, Q Shi, C D Rodgers, A Klip, M Vranic.   

Abstract

We have previously demonstrated that chronic hyperglycemia per se decreases GLUT4 glucose transporter expression and plasma membrane content in mildly streptozotocin- (STZ) diabetic rats (Biochem. J. 284, 341-348, 1992). In the present study, we investigated the effect of an acute rise in glycemia on muscle GLUT4 and GLUT1 protein contents in the plasma membrane, in the absence of insulin elevation. Four experimental groups of rats were analyzed in the postabsorptive state: 1. Control rats. 2. Hyperglycemic STZ-diabetic rats with moderately reduced fasting insulin levels. 3. STZ-diabetic rats made normoglycemic with phlorizin treatment. 4. Phlorizin-treated (normoglycemic) STZ-diabetic rats infused with glucose for 40 min. The uniqueness of the latter model is that glycemia can be rapidly raised without any concomitant increase in plasma insulin levels. Plasma membranes were isolated from hindlimb muscle and GLUT1 and GLUT4 proteins amounts determined by Western blot analysis. As predicted, STZ-diabetes caused a significant decrease in the abundance of GLUT4 in the isolated plasma membranes. Normalization of glycemia for 3 d with phlorizin treatment restored plasma membrane GLUT4 content in muscle of STZ-diabetic rats. A sudden rise in glycemia over a period of 40 min caused the GLUT4 levels in the plasma membrane fraction to decrease to those of nontreated STZ-diabetic rats. In contrast to the GLUT4 transporter, plasma membrane GLUT1 abundance was not changed by the acute glucose challenge. It is concluded that glucose can have regulatory effect by acutely reducing plasma membrane GLUT4 protein contents in rat skeletal muscle. We hypothesize that this glucose-induced downregulation of plasma membrane GLUT4 could represent a protective mechanism against excessive glucose uptake under hyperglycemic conditions accompanied by insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403566     DOI: 10.1385/ENDO:10:1:13

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  23 in total

1.  Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle.

Authors:  A Marette; E Burdett; A Douen; M Vranic; A Klip
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

2.  Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms.

Authors:  G W Gould; H M Thomas; T J Jess; G I Bell
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

3.  Effects of glucose and insulin on development of impaired insulin action in muscle.

Authors:  B F Hansen; S A Hansen; T Ploug; J F Bak; E A Richter
Journal:  Am J Physiol       Date:  1992-04

4.  Insulin-induced translocation of glucose transporters in rat hindlimb muscles.

Authors:  A Klip; T Ramlal; D A Young; J O Holloszy
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

5.  Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs.

Authors:  S J Fisher; M Lekas; Z Q Shi; D Bilinski; G Carvalho; A Giacca; M Vranic
Journal:  Diabetes       Date:  1997-11       Impact factor: 9.461

6.  Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.

Authors:  J R Zierath; D Galuska; L A Nolte; A Thörne; J S Kristensen; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

7.  Glucoregulation in alloxan-diabetic dogs.

Authors:  B Lussier; M Vranic; N Kovacevic; G Hetenyi
Journal:  Metabolism       Date:  1986-01       Impact factor: 8.694

8.  Characterization of glucose transporter-enriched membranes from rat skeletal muscle: assessment of endothelial cell contamination and presence of sarcoplasmic reticulum and transverse tubules.

Authors:  A G Douen; E Burdett; T Ramlal; S Rastogi; M Vranic; A Klip
Journal:  Endocrinology       Date:  1991-01       Impact factor: 4.736

9.  Acute hyperglycemia provides an insulin-independent inducer for GLUT4 translocation in C2C12 myotubes and rat skeletal muscle.

Authors:  P Galante; L Mosthaf; M Kellerer; L Berti; S Tippmer; B Bossenmaier; T Fujiwara; A Okuno; H Horikoshi; H U Häring
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

10.  Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.

Authors:  B B Kahn; G I Shulman; R A DeFronzo; S W Cushman; L Rossetti
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

View more
  4 in total

1.  Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells.

Authors:  V Aas; E T Kase; R Solberg; J Jensen; A C Rustan
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

2.  Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes.

Authors:  Koji Sato; Takeshi Nishijima; Takumi Yokokawa; Satoshi Fujita
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

3.  Decrease of Plasma Glucose by Hibiscus taiwanensis in Type-1-Like Diabetic Rats.

Authors:  Lin-Yu Wang; Hsien-Hui Chung; Juei-Tang Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

4.  Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4.

Authors:  Joshua Runtuwene; Kai-Chun Cheng; Akihiro Asakawa; Haruka Amitani; Marie Amitani; Akinori Morinaga; Yoshiyuki Takimoto; Bernabas Harold Ralph Kairupan; Akio Inui
Journal:  Drug Des Devel Ther       Date:  2016-07-07       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.